Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor (Q41424778)

From Wikidata
Jump to navigation Jump to search
scientific article published on 13 February 2009
edit
Language Label Description Also known as
English
Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor
scientific article published on 13 February 2009

    Statements

    Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor (English)
    1 reference
    L Zhao
    1 reference
    T Ding
    1 reference
    T Cyrus
    1 reference
    Y Cheng
    1 reference
    H Tian
    1 reference
    1 reference
    R Falotico
    1 reference
    D Praticò
    1 reference
    13 February 2009
    1 reference
    156
    1 reference
    774-785
    1 reference
    5
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit